InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（11 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Heerma Peter, Directeur Commercial. Director active across 1 company, notably Travere Therapeutics, Inc.. Cumulatively, 22 reports have been recorded. Breakdown: 0 buy · 11 sells. Total volume traded: €945k. Activity tracked since 13 August 2021. The latest transaction was filed on 13 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Heerma Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
14,000 股0Common StockSEC:0001789617-26-000002:0
7,215 股@ US$41.92880.0054% mcap39.7% 占其流量Common StockSEC:0001789617-26-000002:1
26,120 股0Common StockSEC:0001789617-26-000001:0
4,980 股@ US$40.0017.9% 占其流量Common StockSEC:0001789617-25-000009:0
5,591 股@ US$35.0021.8% 占其流量Common StockSEC:0001789617-25-000007:0
2,662 股@ US$30.0011.3% 占其流量Common StockSEC:0001789617-25-000006:0
891 股0Common StockSEC:0001789617-25-000004:0
4,920 股Common StockSEC:0001415889-25-012057:0
8,000 股Common StockSEC:0001415889-25-003821:0
21,500 股0Common StockSEC:0001415889-25-003063:0
1,584 股@ US$18.94087.4% 占其流量Common StockSEC:0001415889-25-002001:0
6,750 股0Common StockSEC:0001415889-24-023092:0
25,000 股0Common StockSEC:0001415889-24-002282:0
1,559 股@ US$9.06843.3% 占其流量Common StockSEC:0001415889-24-001797:0
3,091 股@ US$8.25116.3% 占其流量Common StockSEC:0001209191-23-051885:0
20,250 股0Common StockSEC:0001209191-23-006425:0
1,550 股@ US$21.90448.0% 占其流量Common StockSEC:0001209191-23-005031:0
3,042 股@ US$25.6820.1% 占其流量Common StockSEC:0001209191-22-053018:0
9,840 股0Common StockSEC:0001209191-22-006363:0
1,875 股@ US$24.984.4% 占其流量Common StockSEC:0001209191-22-005082:0
3,058 股@ US$24.76986.9% 占其流量Common StockSEC:0001209191-21-059353:0
4,500 股0Common StockSEC:0001209191-21-052085:0
22 条申报中的 22 条
About Heerma Peter
Heerma Peter is Directeur Commercial at Travere Therapeutics, Inc. The 22 filings recorded cover the period from 2021-08-17 to 2026-04-15 in the sampled filings, with sales of EUR 945030 and no purchases.
